impact factor, citescore
logo
 

Clinical and Experimental Rheumatology is a monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983. The journal includes annual monothematic issues on the following topics:

The monothematic issue on Myositis is also the official organ of the International Myositis Society (iMyoS, https://imyos.org).

Articles submitted on these topics, once accepted are published ahead-of-print online, and subsequently included in the correspondent monothematic issue.

Editor-in-Chief
Stefano Bombardieri, MD

Environmental Rheumatology

LER & CER: Letter to the Editor Rheumatology

Letter to Editor Rheumatology: Commentaries and Controversies (LER) has been an online forum for a stronger voice and a wider audience for critical and dissenting views in rheumatology and related disciplines. It has joined forces with Clinical and Experimental Rheumatology to achieve the deserved wider audience.

Letters can be submitted solely to: https://www.clinexprheumatol.org, please read Authors’ Guidelines.

Page charge

A page charge of €130.00 will be assessed for all articles published. Instructions for payment will be sent to authors along with the proofs. There is no charge for solicited articles.

Education and CME

 

last archive

Quality

The 5 most viewed PDFs in the last 7 days
in press from 6 months ago (One year in review excluded)

From 12/11/2024 to 19/11/2024

CER17217
Free to view
65 click

Translation and validation in Italian of the methotrexate intolerance severity score for children and adults with arthritis
G. Tarantino, R. Nicolai, A. Aquilani, A. Tomasini, A. Celano, A. Pucacco, S. Magni-Manzoni, F. De Benedetti, E. Marasco

Rheumatology Abstract

 

CER17455
Free to view
59 click

Understanding mechanisms of JAK1 inhibition on synovial fibroblasts using combinatorial approaches of bulk and single cell RNAseq analyses
Y. Son, D. Korenfeld, A. Suarez-Fueyo, M. Ruzek, J. Wang, B. Harvey

Rheumatology Abstract

 

CER17808
Free to view
56 click

A charter to improve care for systemic lupus erythematosus
M. Mosca, J. Andersen, P. Wildman, S. Manzi, Z. Amoura, I. Bultink, O.A. Monticielo, S. Navarra, S. Pettersson

Rheumatology Abstract

 

CER17790
Free to view
40 click

Efficacy of physiotherapy treatment in medium and long term in adults with fibromyalgia: an umbrella of systematic reviews
E. Carrasco-Vega, S. Guiducci, F. Nacci, S. Bellando Randone, C. Bevilacqua, M. Gonzalez-Sanchez, L. Barni

Rheumatology Abstract

 

CER17449
Free to view
38 click

Abatacept and tofacitinib in refractory sarcoidosis: drug survival, safety, and treatment response
H.C.B. Leffers, B. Baslund, J. Lindhardsen, S.B. Krintel, N. Graudal

Rheumatology Abstract

 

The 5 most viewed Abstracts in the last 7 days
in press from 6 months ago (One year in review excluded)

From 12/11/2024 to 19/11/2024

CER17808
Free to view
572 click

A charter to improve care for systemic lupus erythematosus
M. Mosca, J. Andersen, P. Wildman, S. Manzi, Z. Amoura, I. Bultink, O.A. Monticielo, S. Navarra, S. Pettersson

Rheumatology Abstract

 

CER17884
122 click

IgA vasculitis with nephritis: an overview of the pathogenesis and clinical characteristic
Y. Zhang, G. Xu

Rheumatology Abstract

 

CER17420
Free to view
67 click

Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
A. Ruyssen-Witrand, C. Dimeglio, E. Nogue, N. Molinary, T. Pham, C. Gaujoux-Viala, C. Miceli-Richard, O. Fogel, F. Herin, G. Martin-Blondel, F. Berenbaum, V. Breuil, I. Chary-Valckenaere, C. Confavreux, V. Devauchelle-Pensec, B. Fautrel, R.-M. Flipo, D. M

Rheumatology Abstract

 

CER17790
Free to view
57 click

Efficacy of physiotherapy treatment in medium and long term in adults with fibromyalgia: an umbrella of systematic reviews
E. Carrasco-Vega, S. Guiducci, F. Nacci, S. Bellando Randone, C. Bevilacqua, M. Gonzalez-Sanchez, L. Barni

Rheumatology Abstract

 

CER17712
Free to view
55 click

Brepocitinib, a potent and selective TYK2/JAK1 inhibitor: scientific and clinical rationale for dermatomyositis
J.J. Paik, J. Vencovský, C. Charles-Schoeman, G.C. Wright, R.A. Vleugels, A.S. Goriounova, P.N. Mudd, Jr, R. Aggarwal

Rheumatology Abstract